News + Filings Transactions Holdings
|
Boxer Capital, LLC
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/23/2023 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 34.8k | $14.19 | $494.5k | | 08/23/2023 |
| 08/23/2023 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 95.5k | $15.63 | $1.5M | | 08/23/2023 |
| 08/23/2023 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 219.6k | $16.87 | $3.7M | | 08/23/2023 |
| 08/11/2023 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 475k | $5.15 | $2.4M | See footnote | 08/11/2023 |
| 08/11/2023 | Tango Therapeutics, Inc. | | Purchase | Prefunded Warrant | 2.3M | $5.15 | $12.1M | | 08/11/2023 |
| 08/11/2023 | Mirati Therapeutics, Inc. | MRTX | Purchase | Common Stock | 1.2M | $27.80 | $33.4M | | 08/11/2023 |
| 08/11/2023 | Mirati Therapeutics, Inc. | MRTX | Purchase | Common Stock | 57.5k | $27.80 | $1.6M | See Footnote | 08/11/2023 |
| 08/11/2023 | Mirati Therapeutics, Inc. | MRTX | Purchase | Common Stock | 57.5k | $27.80 | $1.6M | See Footnote | 08/11/2023 |
| 08/11/2023 | Mirati Therapeutics, Inc. | MRTX | Purchase | Common Stock | 1.2M | $27.80 | $33.4M | | 08/11/2023 |
| 05/22/2023 | Rain Oncology Inc. | RAIN | Sale | Common Stock | 995k | $1.25 | $1.2M | | 05/22/2023 |
| 10/13/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 70k | $4.65 | $325.2k | | 10/11/2022 |
| 10/12/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 50k | $4.43 | $221.6k | | 10/11/2022 |
| 10/11/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 117k | $4.25 | $497.7k | | 10/11/2022 |
| 10/06/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 70.4k | $4.06 | $286.1k | | 10/04/2022 |
| 10/05/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 45.5k | $3.93 | $178.6k | | 10/04/2022 |
| 10/05/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 40.5k | $3.84 | $155.4k | | 10/04/2022 |
| 10/04/2022 | Tango Therapeutics, Inc. | | Purchase | Common Stock | 25.6k | $3.67 | $94k | | 10/04/2022 |
| 03/17/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 575.2k | $35.25 | $20.3M | | 03/17/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 88.1k | $41.84 | $3.7M | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 9.4k | $43.36 | $406.1k | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 33.3k | $44.44 | $1.5M | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 7.5k | $45.48 | $340.3k | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 29.6k | $41.84 | $1.2M | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 3.1k | $43.36 | $136.1k | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 11.2k | $44.44 | $497.7k | | 01/03/2022 |
| 01/04/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 2.5k | $45.48 | $114.5k | | 01/03/2022 |
| 01/03/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 432.9k | $47.65 | $20.6M | | 01/03/2022 |
| 01/03/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 39.5k | $49.37 | $1.9M | | 01/03/2022 |
| 01/03/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 17.2k | $50.63 | $869.5k | | 01/03/2022 |
| 01/03/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 23.4k | $47.63 | $1.1M | | 01/03/2022 |
| 01/03/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 1.7k | $49.37 | $83k | | 01/03/2022 |
| 01/03/2022 | iTeos Therapeutics, Inc. | ITOS | Sale | Common Stock | 731 | $50.63 | $37k | | 01/03/2022 |
| 12/17/2021 | Tyra Biosciences, Inc. | | Purchase | Common Stock | 125k | $13.12 | $1.6M | | 12/17/2021 |
| 11/24/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 200k | $1.57 | $313.7k | | 11/22/2021 |
| 11/22/2021 | Odonate Therapeutics, Inc. | ODT | Sale | Common Stock | 200k | $1.55 | $309.7k | | 11/22/2021 |
|
|